Healthcare provider profile · identity verified

Richard Cam, DO

Internal Medicine · PORTLAND, OR · NPI 1316438468

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	716	200
Amlodipine Besylate	Amlodipine Besylate	423	121
Levothyroxine Sodium	Levothyroxine Sodium	377	100
Omeprazole	Omeprazole	316	89
Losartan Potassium	Losartan Potassium	278	90
Lisinopril	Lisinopril	253	70
Trazodone Hcl	Trazodone Hcl	230	53
Rosuvastatin Calcium	Rosuvastatin Calcium	215	66
Simvastatin	Simvastatin	172	45
Escitalopram Oxalate	Escitalopram Oxalate	153	33
Metformin Hcl	Metformin Hcl	152	39
Metoprolol Succinate	Metoprolol Succinate	149	46
Tamsulosin Hcl	Tamsulosin Hcl	147	53
Gabapentin	Gabapentin	140	43
Hydrochlorothiazide	Hydrochlorothiazide	131	39
Metformin Hcl Er	Metformin Hcl	127	37
Pravastatin Sodium	Pravastatin Sodium	124	34
Alendronate Sodium	Alendronate Sodium	112	34
Pantoprazole Sodium	Pantoprazole Sodium	100	26
Eliquis	Apixaban	99	26
Albuterol Sulfate Hfa	Albuterol Sulfate	96	39
Donepezil Hcl	Donepezil Hcl	91	14
Potassium Chloride	Potassium Chloride	91	31
Glipizide Er	Glipizide	89	25
Oxycodone Hcl	Oxycodone Hcl	89	25
Finasteride	Finasteride	81	22
Sertraline Hcl	Sertraline Hcl	81	22
Fluticasone Propionate	Fluticasone Propionate	79	31
Furosemide	Furosemide	77	25
Duloxetine Hcl	Duloxetine Hcl	74	22
Tramadol Hcl	Tramadol Hcl	59	23
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	58	15
Mirtazapine	Mirtazapine	58	14
Allopurinol	Allopurinol	57	20
Jardiance	Empagliflozin	57	15
Metoprolol Tartrate	Metoprolol Tartrate	54	16
Atenolol	Atenolol	53	15
Memantine Hcl	Memantine Hcl	51	suppressed
Famotidine	Famotidine	49	12
Bupropion Xl	Bupropion Hcl	48	16
Citalopram Hbr	Citalopram Hydrobromide	47	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	13
Spironolactone	Spironolactone	46	16
Triamcinolone Acetonide	Triamcinolone Acetonide	46	28
Ezetimibe	Ezetimibe	45	suppressed
Lovastatin	Lovastatin	44	15
Carvedilol	Carvedilol	43	13
Valsartan	Valsartan	43	14
Lorazepam	Lorazepam	42	14
Hydroxyzine Hcl	Hydroxyzine Hcl	41	15
Montelukast Sodium	Montelukast Sodium	41	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	14
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Bupropion Hcl Sr	Bupropion Hcl	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	38	11
Warfarin Sodium	Warfarin Sodium	38	12
Celecoxib	Celecoxib	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Ozempic	Semaglutide	29	suppressed
Prednisone	Prednisone	29	13
Terazosin Hcl	Terazosin Hcl	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	15
Clonazepam	Clonazepam	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Ondansetron Odt	Ondansetron	26	13
Benazepril Hcl	Benazepril Hcl	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Lactulose	Lactulose	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Topiramate	Topiramate	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	20
Synthroid	Levothyroxine Sodium	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Digoxin	Digoxin	19	suppressed
Estradiol	Estradiol	19	suppressed
Glipizide	Glipizide	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Glycopyrrolate	Glycopyrrolate	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Naproxen	Naproxen	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Nystatin	Nystatin	15	suppressed
Timolol Maleate	Timolol Maleate	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Rivastigmine	Rivastigmine	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Nadolol	Nadolol	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Letrozole	Letrozole	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error